Antiplatelet resistance is a complex, multifactorial phenomenon that may require individualized monitoring and treatment optimization in specific clinical scenarios.
Antiplatelet resistance monitoring should not yet alter practice; leaves open standardized definitions and targeted prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ševčíková et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: